Sartorius Closes Acquisition of TAP Biosystems Group plc
Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully completed its acquisition of UK company TAP Biosystems Group plc last Monday.
Sartorius is a renowned supplier of laboratory equipment and services, dedicated to providing high-quality solutions for researchers, laboratories, and biopharmaceutical manufacturers. With a commitment to excellence, Sartorius supports scientific endeavors by delivering reliable instruments and consumables, contributing to advancements in research and bioprocessing.
SartoriusThe cash offer made through Sartorius’ wholly owned subsidiary Sartorius Stedim Biotech valued TAP Biosystems Group plc at approximately €33 million and had been approved by TAP Biosystems’ shareholders on November 21, 2013.
The takeover of TAP Biosystems Group plc will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development. Founded in 1987, the company is headquartered in Royston, UK, generated sales revenue of approximately €26 million in 2012/2013 and employs around 160 people worldwide.
This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.
To continue reading this article, sign up for FREE to
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.